Partners
BSP Pharmaceuticals - Innovation Partner
BSP Pharmaceuticals is a Contract Development and Manufacturing Organization fully dedicated to antineoplastic drugs, designed to handle the complexity of biopharmaceutical products and offering customized services to support its client from development to commercial manufacturing of injectables and oral formulations. BSP Pharmaceuticals is focused on innovative therapies such as Proteosome Inhibitors, Antibody Drug Conjugates (ADCs) , Liposomal formulations, handling the major platforms of ADC compounds currently in clinical and commercial phase.
AsymBio - Exhibition Partner
AsymBio is the emerging business unit of Asymchem Group striving to become a technology-driven, fully-empowered one stop CDMO services platform for biologic (mAb, ADC, plamsid&mRNA), offering customized services with outstanding quality and efficient performance. We have built an integrated and comprehensive CDMO service platform for ADC drugs (payload-linker, mAb, conjugation), which including but not limited to development, manufacturing, quality control and regulatory affairs. Our onestop ADC CDMO service platform is able to efficiently empower ADCs.
Cytiva - Exhibition Partner
Cytiva and Pall Life Sciences have come together to deliver the breadth, depth, and scale researchers and biopharma need to advance future therapeutics— from discovery to delivery. Together, as Cytiva, we supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes wellrecognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™.
Veranova - Exhibition Partner
Veranova is a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients for pharma and biotech customers. Veranova’s global team of highly skilled process chemists and analytical scientists possess over a decade of experience developing and scaling up processes for linking small molecule payloads to polymers in support of antibody-drug conjugates and polymer drug conjugates.
Sterling - Event Partner
Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO), specialising in complex and hazardous science. Our dedicated bioconjugation and ADC facility in the UK supports customer’s projects from development to preclinical and clinical manufacture.
This specialised team is supported by high potency small molecule experts at our Wisconsin, US site providing integrated ADC services, including toxin linker manufacturing.
Sterling has six facilities across the UK, USA and Europe, employing more than 1,350 people.
www.sterlingpharmasolutions.com
